Pharmacogenomic – Interview with Dr. David Flockhart

Dr. David Flockhart is a pharmacogeneticist at the Indiana University School of Medicine who was diagnosed with advanced gliobastoma multiforme, a type of brain cancer. In this latest edition in our continuing series of conversations about cancer with Dr. Flockhart, he answers the question: “Where do you think American policy on cancer really needs to improve?” In his opinion, the biggest impact would come from not more technology or better science, but people who could help patients navigate their treatment.

 

Interview with Dr. David Flockhart on Pharmacogenomics